Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Researchers are exploring the use of nanoparticles to treat glioblastoma multiforme, a type of brain tumor. Some studies have shown promise for using surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome therapeutic resistance in this disease. The development of nanotherapies for cancer treatment is an area of ongoing research, with various approaches and applications being investigated.
Full coverage
12345678